The Complaint alleges that during the Class Period, Defendants issued statements that were materially false and misleading and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants misled investors by misrepresenting and/or failing to disclose that: (i) the Company’s organic growth is plummeting; (ii) the Company’s recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (iii) Aterian’s purported artificial intelligence software is a flawed product that lacks customer interest; (iv) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Aterian Inc. Common Stock Ater Securities Litigation
May 17, 2021 | Aterian Inc. Common Stock NASDAQ: ATER | Case Status: Filed
Filing Deadline: July 12, 2021
If you purchased a significant amount of shares of Aterian Inc. Common Stock (NASDAQ: ATER), you have certain options. Investors should contact us before July 12, 2021.
Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Aterian Inc. Common Stock
First Identified Complaint
Andrew G. Tate, et al. v. Aterian, Inc., et al.
First Identified Complaint Filings
|#||Document Title||Filing Date|
|1||Class Action Complaint for Violation of the Federal Securities Laws||May 13th, 2021|
|2||U.S. District Court Civil Docket||May 14th, 2021|